Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, July 2011

Sort by: Newest first Oldest first A-Z Z-A

  • New NHS information web portal launched

    29 JUL 2011 15:53

    Patients and healthcare professionals can now exchange and use information through a web portal launched this week (25 July 2011).

  • COPD quality standard published by NICE

    29 JUL 2011 15:48

    A new quality standard on chronic obstructive pulmonary disease has been published by the National Institute for Health and Clinical Excellence.

  • Retigabine approved for epilepsy

    29 JUL 2011 15:43

    Retigabine has been approved for controlling seizures in adults with epilepsy by the National Institute for Health and Clinical Excellence.

  • NICE approves dexamethasone for macular oedema

    29 JUL 2011 15:38

    Dexamethasone has been approved in England and Wales for the treatment of patients with macular oedema by the National Institute for Health and Clinical Excellence.

  • Students in examination hall (Mrloz/Dreamstime.com)

    Preregistration trainees claim exam conditions affected performance

    28 JUL 2011 16:07

    More than 70 preregistration trainees have complained to their student body because they are concerned that increased stress levels might have affected their performance in this year’s registration examination. They say their increased stress was brought about because of the way the examination was organised.

  • Whispering (Alba/Dreamstime.com)

    Professionals should be prepared to whistle-blow or risk investigation

    27 JUL 2011 15:22

    Health regulators should send a clear signal to professionals that they may be investigated if they fail to raise concerns about colleagues, MPs have indicated. That view is supported by the General Pharmaceutical Council.

  • pharmaceutical scientist (dreamstime.com)

    Pharmaceutical scientists welcomed into Society’s fold

    27 JUL 2011 15:15

    Pharmaceutical scientists will be able to join the Royal Pharmaceutical Society from October following a vote by RPS members. A special resolution ballot achieved a voter turnout of 8,806 members (24.8 per cent), with 76 per cent voting in favour of creating an RPS pharmaceutical scientist membership category.

  • Alastair Buxton

    Limited opportunities in first wave of patient choice reforms

    26 JUL 2011 17:23

    Diagnostic services and home chemotherapy care are two areas where community pharmacists could provide services under Government plans to open up the NHS to "any qualified provider" (AQP), according to the Pharmaceutical Services Negotiating Committee.

  • Restrictions placed on pioglitazone use

    25 JUL 2011 15:18

    Medicines containing pioglitazone (Actos and Competact) should no longer be prescribed for patients who have bladder cancer or a history of the disease, as well as others who have uninvestigated blood in their urine, the European Medicines Agency has advised.

  • ProScript software approved for 2D-Rx in Wales

    25 JUL 2011 9:40

    Pharmacy software company Rx Systems has received approval from the Welsh Assembly Government to roll out its 2D-Rx ProScript software across Wales. The system streamlines dispensing for pharmacists by allowing them to scan 2D-barcoded prescriptions.

  • Varenicline’s benefits outweigh CV risks says EMA

    22 JUL 2011 15:15

    Varenicline’s benefits in helping people to stop smoking outweigh the increased risk of cardiovascular (CV) events, the European Medicines Agency has confirmed.

  • Heart and stethoscope (Dreamstime.com/Krishna creations)

    NHS has "missed the boat" for ARB switching

    22 JUL 2011 15:10

    Switching patients to generic losartan does not represent good value for money for the NHS, a leading cardiology pharmacist has warned.

  • Elderly woman (Dreamstime.com/Ivonne Wierink)

    Antidepressants no benefit to dementia patients

    22 JUL 2011 15:00

    Patients with dementia do not benefit from taking sertraline or mirtazapine to treat depression, and are at an increased risk of side effects from the drugs, according to a UK study published online (The Lancet, 18 July 2011).

  • Man given pills (Dreamstime.com/Yuri Arcurs)

    Pain relief eases dementia symptoms

    22 JUL 2011 14:49

    Improved pain management can reduce agitation and aggression in nursing home residents who have moderate-to-severe dementia, a Norwegian study has shown. Systematic treatment with analgesics could also help reduce the use of antipsychotic drugs in this patient population, the authors suggest.

  • Falls risk with change of non-SSRI

    22 JUL 2011 13:23

    Nursing home residents are at a high risk of falls following a change in non-selective serotonin reuptake inhibitor (SSRI) medication, reveals a study published online (Journal of Gerontology, 15 July 2011).

  • Polypharmacy-death link among elderly remains unclear

    22 JUL 2011 13:11

    The relationship between polypharmacy and mortality in the elderly remains unclear, according to research published in Drugs & Ageing (2011;28:547).

  • MPharm course graduates

    UCLan’s first MPharm students graduate

    22 JUL 2011 13:04

    The first cohort of students has graduated from the University of Central Lancashire’s MPharm course, which was established four years ago.

  • Triptorelin benefit in breast cancer

    22 JUL 2011 12:50

    Triptorelin, a gonadotropin-releasing hormone (GnRH) analogue, reduces the incidence of chemotherapy-induced early menopause in young women with breast cancer, a phase III study reveals (JAMA 2011;306:269).

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.